1 5066 150 PHTHALATES SUPPRESS TYPE I INTERFERON IN HUMAN PLASMACYTOID DENDRITIC CELLS VIA EPIGENETIC REGULATION. BACKGROUND: EXPOSURE TO ENVIRONMENTAL ENDOCRINE-DISRUPTING CHEMICALS (EDCS) IS ASSOCIATED WITH ALLERGY, CHRONIC INFLAMMATION, AND IMMUNODEFICIENCY. PHTHALATES, THE COMMON EDCS USED IN PLASTIC INDUSTRY, MAY ACT AS ADJUVANTS TO DISRUPT IMMUNE SYSTEM AND ENHANCE ALLERGY. PLASMACYTOID DCS (PDCS) ARE PREDOMINANT CELLS SECRETING TYPE I INTERFERON (IFN) AGAINST INFECTION AND ARE PROFESSIONAL ANTIGEN-PRESENTING CELLS IN REGULATING ADAPTIVE IMMUNITY. HOWEVER, THE EFFECTS OF PHTHALATES ON THE FUNCTION OF PDCS ARE UNKNOWN. METHODS: CIRCULATING PDCS WERE ISOLATED FROM HEALTHY SUBJECTS, WERE PRETREATED WITH DIETHYLHEXYL PHTHALATE (DEHP) AND BUTYL BENZYL PHTHALATE (BBP), AND WERE STIMULATED WITH TOLL-LIKE RECEPTOR (TLR)-9 AGONIST CPG. IFN-ALPHA/IFN-BETA LEVELS, SURFACE MARKERS, AND T-CELL STIMULATORY FUNCTION WERE INVESTIGATED USING ELISA, FLOW CYTOMETRY, AND PDC/T-CELL COCULTURE ASSAY. MECHANISMS WERE INVESTIGATED USING RECEPTOR ANTAGONISTS, PATHWAY INHIBITORS, WESTERN BLOTTING, AND CHROMATIN IMMUNOPRECIPITATION. RESULTS: DIETHYLHEXYL PHTHALATE AND BUTYL BENZYL PHTHALATE SUPPRESSED CPG-INDUCED IFN-ALPHA/IFN-BETA EXPRESSION IN PDCS, AND THE EFFECT WAS REVERSED BY ARYL HYDROCARBON RECEPTOR (AHR) ANTAGONIST. DIETHYLHEXYL PHTHALATE SUPPRESSED CPG-ACTIVATED MITOGEN-ACTIVATED PROTEIN KINASE (MAPK)-MEK1/2-ERK-ELK1 AND NFKAPPAB SIGNALING PATHWAYS. DIETHYLHEXYL PHTHALATE SUPPRESSED CPG-INDUCED INTERFERON REGULATORY FACTOR (IRF)-7 EXPRESSION BY SUPPRESSING HISTONE H3K4 TRIMETHYLATION AT IRF7 GENE PROMOTER REGION THROUGH INHIBITING TRANSLOCATION OF H3K4-SPECIFIC TRIMETHYLTRANSFERASE WDR5 FROM CYTOPLASM INTO NUCLEUS. BUTYL BENZYL PHTHALATE OR DIETHYLHEXYL PHTHALATE-TREATED PDCS SUPPRESSED IFN-GAMMA BUT ENHANCED IL-13 PRODUCTION BY CD4+ T CELLS. CONCLUSION: PHTHALATES MAY INTERFERE WITH IMMUNITY AGAINST INFECTION AND PROMOTE THE DEVIATION OF TH2 RESPONSE TO INCREASE ALLERGY BY ACTING ON HUMAN PDCS VIA SUPPRESSING IFN-ALPHA/IFN-BETA EXPRESSION AND MODULATING THE ABILITY TO STIMULATE T-CELL RESPONSES. 2013 2 694 26 BREAST MILK MESENCHYMAL STEM CELLS AND/OR DERIVED EXOSOMES MITIGATED ADENINE-INDUCED NEPHROPATHY VIA MODULATING RENAL AUTOPHAGY AND FIBROTIC SIGNALING PATHWAYS AND THEIR EPIGENETIC REGULATIONS. CHRONIC KIDNEY DISEASE (CKD), A GLOBAL HEALTH CONCERN, IS HIGHLY PREVALENT AMONG ADULTS. PRESENTLY, THERE ARE LIMITED THERAPEUTIC OPTIONS TO RESTORE KIDNEY FUNCTION. THIS STUDY AIMED TO INVESTIGATE THE THERAPEUTIC POTENTIAL OF BREAST MILK MESENCHYMAL STEM CELLS (BR-MSCS) AND THEIR DERIVED EXOSOMES IN CKD. EIGHTY ADULT MALE SPRAGUE DAWLEY RATS WERE RANDOMLY ASSIGNED TO ONE OF SIX GROUPS, INCLUDING CONTROL, NEPHROPATHY, NEPHROPATHY + CONDITIONED MEDIA (CM), NEPHROPATHY + BR-MSCS, NEPHROPATHY + BR-MSCS DERIVED EXOSOMES (BR-MSCS-EXOS), AND NEPHROPATHY + BR-MSCS + BR-MSCS-EXOS. BEFORE ADMINISTRATION, BR-MSCS AND BR-MSCS-EXOS WERE ISOLATED, IDENTIFIED, AND LABELED WITH PKH-26. SOX2, NANOG, AND OCT3/4 EXPRESSION LEVELS IN BR-MSCS AND MIR-29B, MIR-181, AND LET-7B IN BOTH BR-MSCS AND BR-MSCS-EXOS WERE ASSAYED. TWELVE WEEKS AFTER TRANSPLANTATION, RENAL FUNCTION TESTS, OXIDATIVE STRESS, EXPRESSION OF THE LONG NON-CODING RNA SNHG-7, AUTOPHAGY, FIBROSIS, AND EXPRESSION OF PROFIBROTIC MIR-34A AND ANTIFIBROTIC MIR-29B, MIR-181, AND LET-7B WERE MEASURED IN RENAL TISSUES. IMMUNOHISTOCHEMICAL ANALYSIS FOR RENAL BECLIN-1, LC3-II, AND P62, MASSON TRICHOME STAINING, AND HISTOPATHOLOGICAL EXAMINATION OF KIDNEY TISSUES WERE ALSO PERFORMED. THE RESULTS SHOWED THAT BR-MSCS EXPRESSED SOX2, NANOG, AND OCT3/4, WHILE BOTH BR-MSCS AND BR-MSCS-EXOS EXPRESSED ANTIFIBROTIC MIR-181, MIR-29B, AND LET-7B, WITH HIGHER EXPRESSION LEVELS IN EXOSOMES THAN IN BR-MSCS. INTERESTINGLY, THE ADMINISTRATION OF BR-MSCS + EXOS, EXOS, AND BR-MSCS IMPROVED RENAL FUNCTION TESTS, REDUCED RENAL OXIDATIVE STRESS, UPREGULATED THE RENAL EXPRESSION OF SNHG-7, AMPK, ULK-1, BECLIN-1, LC3, MIR-29B, MIR-181, LET-7B, AND SMAD-7, DOWNREGULATED THE RENAL EXPRESSION OF MIR-34A, AKT, MTOR, P62, TGF-BETA, SMAD-3, AND COLI-1, AND AMELIORATED RENAL PATHOLOGY. THUS, BR-MSCS AND/OR THEIR DERIVED EXOSOMES APPEAR TO REDUCE ADENINE-INDUCED RENAL DAMAGE BY SECRETING ANTIFIBROTIC MICRORNAS AND POTENTIATE RENAL AUTOPHAGY BY MODULATING SNHG-7 EXPRESSION. 2023 3 766 36 CCL5 SUPPRESSES KLOTHO EXPRESSION VIA P-STAT3/DNA METHYLTRANSFERASE1-MEDIATED PROMOTER HYPERMETHYLATION. BACKGROUND: ENHANCED INFLAMMATION AND REDUCED KLOTHO ARE COMMON FEATURES IN CHRONIC KIDNEY DISEASE (CKD). INFLAMMATION INDUCES DNA HYPERMETHYLATION. THIS STUDY ASSESSED THE PERFORMANCE OF INFLAMMATORY MARKER C-C MOTIF CHEMOKINE 5 (CCL5) IN EPIGENETIC REGULATION OF KLOTHO EXPRESSION. METHODS: FIFTY CKD PATIENTS AND 25 MATCHED CONTROLS WERE ENROLLED, AND SERUM CCL5 LEVEL, SKLOTHO LEVEL, AND DNA METHYLATION WERE EVALUATED IN THESE SUBJECTS. A RENAL INTERSTITIAL FIBROSIS (RIF) MODEL WITH CKD WAS INDUCED IN MICE VIA UNILATERAL URETERAL OBSTRUCTION (UUO) IN VIVO AND HUMAN PROXIMAL TUBULAR EPITHELIAL (HK-2) CELLS TREATED WITH CCL5 IN VITRO. 5-AZA-2'-DEOXYCYTIDINE (5-AZA), A DNA METHYLTRANSFERASE INHIBITOR WAS GIVEN TO UUO MICE. HEMATOXYLIN AND EOSIN (HE) AND MASSON TRICHROME STAINING WERE ADOPTED TO EVALUATE RENAL PATHOLOGICAL CHANGES. METHYLATION-SPECIFIC PCR WAS PERFORMED TO ASSESS DNA METHYLATION OF KLOTHO PROMOTER IN THE PERIPHERAL BLOOD LEUCOCYTES (PBLS) FROM CKD PATIENTS AND OBSTRUCTIVE KIDNEY FROM UUO MICE. CCL5, KLOTHO, AND DNA METHYLTRANSFERASES (DNMTS) WERE DETERMINED BY ELISAS, IMMUNOFLUORESCENCE, OR WESTERN BLOTTING. HK-2 CELLS WERE EXPOSED TO CCL5 WITH OR WITHOUT 5-AZA AND STATTIC, A P-SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) INHIBITOR, AND EXPRESSIONS OF P-STAT3, DNMT1, AND KLOTHO WERE DETERMINED BY WESTERN BLOTTING. RESULTS: CCL5 UPREGULATION CONCOMITANT WITH KLOTHO DOWNREGULATION IN SERUM AND GLOBAL DNA METHYLATION IN PBLS WERE OBSERVED IN CKD SAMPLES. UUO CONTRIBUTED TO SEVERE RENAL INTERSTITIAL FIBROSIS AND ENHANCED EXPRESSIONS OF FIBROTIC MARKERS. MOREOVER, UUO INCREASED THE CCL5 LEVEL, INDUCED KLOTHO PROMOTER METHYLATION, SUPPRESSED KLOTHO LEVEL, ACTIVATED P-STAT3 SIGNALING, AND UPREGULATED DNMT1 LEVEL. A SIMILAR OBSERVATION WAS MADE IN HK-2 CELLS TREATED WITH CCL5. MORE IMPORTANTLY, 5-AZA INHIBITED UUO-INDUCED KLOTHO HYPERMETHYLATION, REVERSED KLOTHO, DOWNREGULATED P-STAT3 EXPRESSIONS, AND AMELIORATED RIF IN VIVO. THE CONSISTENT FINDINGS IN VITRO WERE ALSO OBTAINED IN HK-2 CELLS EXPOSED TO 5-AZA AND STATTIC. CONCLUSION: THE CCL5/P-STAT3/DNMT1 AXIS IS IMPLICATED IN EPIGENETIC REGULATION OF KLOTHO EXPRESSION IN CKD. THIS STUDY PROVIDES NOVEL THERAPEUTIC POSSIBILITIES FOR REVERSAL OF KLOTHO SUPPRESSION BY CKD. 2022 4 6235 36 THE M(6)A DEMETHYLASE FTO PROMOTES RENAL EPITHELIAL-MESENCHYMAL TRANSITION BY REDUCING THE M(6)A MODIFICATION OF LNCRNA GAS5. BACKGROUND: RENAL INTERSTITIAL FIBROSIS (RIF) IS THE MAIN PATHOLOGICAL CHANGE OF A VARIETY OF CHRONIC KIDNEY DISEASES (CKD). EPIGENETIC MODIFICATIONS OF FIBROSIS-PRONE GENES REGULATE RIF PROGRESSION. THIS STUDY AIMED TO INVESTIGATE LONG NON-CODING RNA (LNCRNA) N6-METHYLADENOSINE (M(6)A) MODIFICATION AND ITS ROLE IN REGULATING RIF PROGRESSION. METHODS: UNILATERAL URETERAL OCCLUSION (UUO) WAS EMPLOYED TO CONSTRUCT THE RIF IN VIVO MODEL; AND TGF-BETA1-TREATED HK-2 AND HKC-8 CELLS WERE USED FOR IN VITRO EXPERIMENTS. THE MRNA AND PROTEIN EXPRESSIONS WERE ASSESSED USING QRT-PCR AND WESTERN BLOT. THE PROLIFERATION AND MIGRATION WERE EVALUATED BY EDU ASSAY AND TRANSWELL ASSAY, RESPECTIVELY. IN ADDITION, LEVELS OF INFLAMMATORY CYTOKINES WERE DETERMINED BY ELISA ASSAY AND QRT-PCR. MOREOVER, LNCRNA GAS5 M(6)A LEVEL WAS DETECTED USING ME-RIP ASSAY. HE AND MASSON STAINING WERE EMPLOYED TO EVALUATE FIBROTIC LESIONS OF THE KIDNEY. RESULTS: FTO EXPRESSION WAS ELEVATED IN HK-2 AND HKC-8 CELLS AFTER TGF-BETA1 TREATMENT AND MOUSE KIDNEY TISSUE FOLLOWING UUO, AND LNCRNA GAS5 WAS DOWNREGULATED. LNCRNA GAS5 OVEREXPRESSION OR FTO SILENCING SUPPRESSED TGF-BETA1-INDUCED THE INCREASE OF EMT-RELATED PROTEINS (VIMENTIN, SNAIL AND N-CADHERIN) AND INFLAMMATORY CYTOKINES (IL-6, IL-1BETA AND TNF-ALPHA) LEVELS IN HK-2 CELLS. FTO SUPPRESSED LNCRNA GAS5 EXPRESSION BY REDUCING THE M6A MODIFICATION OF LNCRNA GAS5. ADDITIONALLY, FTO KNOCKDOWN COULD SUPPRESS EMT PROCESS AND INFLAMMATION RESPONSE INDUCED BY TGF-BETA1 AND UUO IN VITRO AND IN VIVO. AS EXPECTED, FTO KNOCKDOWN ABROGATED THE PROMOTION EFFECTS OF LNCRNA GAS5 SILENCING ON TGF-BETA1-INDUCED EMT PROCESS AND INFLAMMATION RESPONSE IN HK-2 AND HKC-8 CELLS. CONCLUSION: FTO PROMOTED EMT PROCESS AND INFLAMMATION RESPONSE THROUGH REDUCING THE M(6)A MODIFICATION OF LNCRNA GAS5. 2022 5 5764 34 SORAFENIB ATTENUATES FIBROTIC HEPATIC INJURY THROUGH MEDIATING LYSINE CROTONYLATION. BACKGROUND: LIVER FIBROSIS IS AN INDEPENDENT CONTRIBUTOR OF CHRONIC LIVER DISEASES, AND REGRESSING LIVER FIBROSIS IS CONSIDERED A POTENTIAL THERAPEUTIC TARGET FOR CHRONIC LIVER DISEASES. WE AIMED TO EXPLORE THE EFFECTS AND MECHANISM OF SORAFENIB IN LIVER FIBROSIS. METHODS: MALE SPRAGUE DAWLEY (SD) RATS WERE SUBJECTED TO SUBCUTANEOUS INJECTION OF CARBON TETRACHLORIDE (CCL(4)) FOR 8 WEEKS TO INDUCE LIVER FIBROSIS AND THEN TREATED WITH SORAFENIB. THE DEGREE OF LIVER FIBROSIS WAS ANALYZED BY HEMATOXYLIN-EOSIN (H&E) STAINING, MASSON STAINING, AND PICROSIRIUS RED (PSR) STAINING. SERUM BIOCHEMICAL INDEXES WERE DETECTED BY FULLY AUTOMATIC BIOCHEMICAL ANALYZER OR ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA). QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION (QRT-PCR) WAS PERFORMED TO DETECT THE EXPRESSION OF PRO-FIBROTIC GENES. IMMUNOHISTOCHEMICAL STAINING AND WESTERN BLOTTING WERE CARRIED OUT TO EVALUATE THE LEVELS OF LYSINE CROTONYLATION. RESULTS: LIVER INDEX WAS REDUCED WITH ORAL SORAFENIB IN CCL(4)-INDUCED RATS. SERUM LIVER FUNCTION (ALANINE AMINOTRANSFERASE (ALT), ASPARTATE AMINOTRANSFERASE (AST), AND TOTAL BILIRUBIN (TBIL)) AND FIBROSIS INDICATORS (TYPE III PROCOLLAGEN (PC-III), HYALURONIC ACID (HA), AND LAMININ (LN)) WERE ATTENUATED WITH SORAFENIB TREATMENT. SORAFENIB IMPROVED THE HEPATIC STRUCTURE AND FIBROTIC PROGRESSION. THE EXPRESSION OF FIBROSIS-RELATED GENES WAS REMARKELY REDUCED WITH SORAFENIB TREATMENT. MEANWHILE, SORAFENIB INHIBITED ALPHA-SMA AND COLLAGEN I CUMULATION INDUCED BY CCL(4) INJECTION. BESIDES, PROTEIN LYSINE CROTONYLATION ESPECIALLY THE CROTONYLATED H2BK12 (H2BK12CR) AND CROTONYLATED H3K18 (H3K18CR) WERE REVERSED BY SORAFENIB, WHICH WERE DECREASED IN RESPONSE TO CCL(4) TREATMENT. SPEARMAN CORRELATION ANALYSIS SHOWN LYSINE CROTONYLATION EXPRESSION WAS NEGATIVELY CORRELATED WITH SERUM FIBROTIC INDICATORS. CONVERSELY, CROTONYLATION-REGULATED ENZYMES, WHICH NEGATIVELY REGULATE PROTEIN CROTONYLATION, WERE INCREASED IN RESPONSE TO CCL(4) TREATMENT, WHILE SORAFENIB REDUCED THEIR EXPRESSION. CONCLUSION: SORAFENIB EXERTS SIGNIFICANT ANTI-FIBROTIC EFFECTS THROUGH MEDIATING CROTONYLATION-REGULATED ENZYMES AND PROTEIN CROTONYLATION IN FIBROTIC RATS. 2022 6 841 28 CHEMOKINES FORM NANOPARTICLES WITH DNA AND CAN SUPERINDUCE TLR-DRIVEN IMMUNE INFLAMMATION. CHEMOKINES CONTROL THE MIGRATORY PATTERNS AND POSITIONING OF IMMUNE CELLS TO ORGANIZE IMMUNE RESPONSES TO PATHOGENS. HOWEVER, MANY CHEMOKINES HAVE BEEN ASSOCIATED WITH SYSTEMIC AUTOIMMUNE DISEASES THAT HAVE CHRONIC IFN SIGNATURES. WE REPORT THAT A SERIES OF CHEMOKINES, INCLUDING CXCL4, CXCL10, CXCL12, AND CCL5, CAN SUPERINDUCE TYPE I IFN (IFN-I) BY TLR9-ACTIVATED PLASMACYTOID DCS (PDCS), INDEPENDENTLY OF THEIR RESPECTIVE KNOWN CHEMOKINE RECEPTORS. MECHANISTICALLY, WE SHOW THAT CHEMOKINES SUCH AS CXCL4 MEDIATE TRANSCRIPTIONAL AND EPIGENETIC CHANGES IN PDCS, MOSTLY TARGETED TO THE IFN-I PATHWAYS. WE DESCRIBE THAT CHEMOKINES PHYSICALLY INTERACT WITH DNA TO FORM NANOPARTICLES THAT PROMOTE CLATHRIN-MEDIATED CELLULAR UPTAKE AND DELIVERY OF DNA IN THE EARLY ENDOSOMES OF PDCS. USING TWO SEPARATE MOUSE MODELS OF SKIN INFLAMMATION, WE OBSERVED THE PRESENCE OF CXCL4 ASSOCIATED WITH DNA IN VIVO. THESE DATA REVEAL A NONCANONICAL ROLE FOR CHEMOKINES TO SERVE AS NUCLEIC ACID DELIVERY VECTORS TO MODULATE TLR SIGNALING, WITH IMPLICATIONS FOR THE CHRONIC PRESENCE OF IFN-I BY PDCS IN AUTOIMMUNE DISEASES. 2022 7 5868 46 SUPPRESSIVE EFFECTS OF METFORMIN ON T-HELPER 1-RELATED CHEMOKINES EXPRESSION IN THE HUMAN MONOCYTIC LEUKEMIA CELL LINE THP-1. PURPOSE OF THE STUDY: TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM) ARE CHRONIC T-CELL-MEDIATED INFLAMMATORY DISEASES. METFORMIN IS A WIDELY USED DRUG FOR TYPE 2 DM THAT REDUCES THE NEED FOR INSULIN IN TYPE 1 DM. HOWEVER, WHETHER METFORMIN HAS AN ANTI-INFLAMMATORY EFFECT FOR TREATING DM IS UNKNOWN. WE INVESTIGATED THE ANTI-INFLAMMATORY MECHANISM OF METFORMIN IN THE HUMAN MONOCYTIC LEUKEMIA CELL LINE THP-1. MATERIALS AND METHODS: THE HUMAN MONOCYTIC LEUKEMIA CELL LINE THP-1 WAS PRETREATED WITH METFORMIN AND STIMULATED WITH LIPOPOLYSACCHARIDE (LPS). THE PRODUCTION OF T-HELPER (TH)-1-RELATED CHEMOKINES INCLUDING INTERFERON-GAMMA-INDUCED PROTEIN-10 (IP-10) AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1), TH2-RELATED CHEMOKINE MACROPHAGE-DERIVED CHEMOKINE, AND THE PROINFLAMMATORY CHEMOKINE TUMOR NECROSIS FACTOR-ALPHA WAS MEASURED USING ENZYME-LINKED IMMUNOSORBENT ASSAY. INTRACELLULAR SIGNALING PATHWAYS WERE INVESTIGATED USING WESTERN BLOT ANALYSIS AND CHROMATIN IMMUNOPRECIPITATION ASSAY. RESULTS: METFORMIN SUPPRESSED LPS-INDUCED IP-10 AND MCP-1 PRODUCTION AS WELL AS LPS-INDUCED PHOSPHORYLATION OF C-JUN N-TERMINAL KINASE (JNK), P38, EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK), AND NUCLEAR FACTOR-KAPPA B (NF-KAPPAB). MOREOVER, METFORMIN SUPPRESSED LPS-INDUCED ACETYLATION OF HISTONES H3 AND H4 AT THE IP-10 PROMOTER. CONCLUSIONS: METFORMIN SUPPRESSED THE PRODUCTION OF TH1-RELATED CHEMOKINES IP-10 AND MCP-1 IN THP-1 CELLS. SUPPRESSIVE EFFECTS OF METFORMIN ON IP-10 PRODUCTION MIGHT BE ATTRIBUTED AT LEAST PARTIALLY TO THE JNK, P38, ERK, AND NF-KAPPAB PATHWAYS AS WELL AS TO EPIGENETIC REGULATION THROUGH THE ACETYLATION OF HISTONES H3 AND H4. THESE RESULTS INDICATED THE THERAPEUTIC ANTI-INFLAMMATORY POTENTIAL OF METFORMIN. 2018 8 2185 41 EPIGENETIC MECHANISMS UNDERLYING HIV-INFECTION INDUCED SUSCEPTIBILITY OF CD4+ T CELLS TO ENHANCED ACTIVATION-INDUCED FASL EXPRESSION AND CELL DEATH. BACKGROUND: CHRONIC IMMUNE ACTIVATION AND CD4 T CELL DEPLETION ARE SIGNIFICANT PATHOGENIC FEATURES OF HIV INFECTION. EXPRESSION OF FAS LIGAND (FASL), A KEY MEDIATOR OF ACTIVATION-INDUCED CELL DEATH IN T CELLS, IS ELEVATED IN PEOPLE LIVING WITH HIV-1 INFECTION (PLWH). HOWEVER, THE EPIGENETIC MECHANISMS UNDERLYING THE ENHANCED INDUCTION OF FASL EXPRESSION IN CD4 T LYMPHOCYTES IN PLWH ARE NOT COMPLETELY ELUCIDATED. HENCE, THE CURRENT WORK EXAMINED THE EFFECT OF HIV INFECTION ON FASL PROMOTER-ASSOCIATED HISTONE MODIFICATIONS AND TRANSCRIPTIONAL REGULATION IN CD4 T LYMPHOCYTES IN PLWH. METHOD: FLOW CYTOMETRIC ANALYSIS WAS PERFORMED TO EXAMINE THE FAS-FASL EXPRESSION ON TOTAL CD4 T CELLS AND NAIVE/MEMORY CD4 T CELL SUBSETS. EPIGENETIC FASL PROMOTER HISTONE MODIFICATIONS WERE INVESTIGATED BY CHROMATIN IMMUNOPRECIPITATION-QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION ANALYSIS USING FRESHLY ISOLATED TOTAL CD4 T LYMPHOCYTES FROM HIV-1 INFECTED AND NONINFECTED INDIVIDUALS. RESULTS: ALL NAIVE/MEMORY CD4 T CELL SUBSETS FROM PLWH SHOWED MARKEDLY GREATER FREQUENCY OF FASL EXPRESSION. NOTABLY, EXAMINATION OF FUNCTIONAL OUTCOME OF FASL/FAS CO-EXPRESSION DEMONSTRATED THE PREFERENTIAL SUSCEPTIBILITY OF TCM AND TEM SUBSETS TO ACTIVATION-INDUCED APOPTOSIS. IMPORTANTLY, THESE CD4 T CELLS COLLECTIVELY DEMONSTRATED A DISTINCT FASL PROMOTER HISTONE PROFILE INVOLVING A COORDINATED CROSS-TALK BETWEEN HISTONE H3 MODIFICATIONS LEADING TO ENHANCED FASL GENE EXPRESSION. SPECIFICALLY, LEVELS OF TRANSCRIPTIONALLY PERMISSIVE HISTONE H3K4-TRIMETHYLATION (H3K4ME3) AND HISTONE H3K9-ACETYLATION (H3K9AC) WERE INCREASED, WITH A CONCOMITANT DECREASE IN THE REPRESSIVE H3K9-TRIMETHYLATION (H3K9ME3). CONCLUSION: THE PRESENT WORK DEMONSTRATES THAT EPIGENETIC MECHANISMS INVOLVING PROMOTER-HISTONE MODIFICATIONS REGULATE TRANSCRIPTIONAL COMPETENCE AND FASL EXPRESSION IN CD4 T CELLS FROM PLWH AND RENDER THEM SUSCEPTIBLE TO ACTIVATION-INDUCED CELL DEATH. 2021 9 1632 30 DNMTS ARE INVOLVED IN TGF-BETA1-INDUCED EPITHELIAL-MESENCHYMAL TRANSITIONS IN AIRWAY EPITHELIAL CELLS. CHRONIC RHINOSINUSITIS (CRS) PATHOGENESIS IS CLOSELY RELATED TO TISSUE REMODELING, INCLUDING EPITHELIAL-MESENCHYMAL TRANSITION (EMT). EPIGENETIC MECHANISMS PLAY KEY ROLES IN EMT. DNA METHYLATION, MEDIATED BY DNA METHYLTRANSFERASES (DNMTS), IS AN EPIGENETIC MARKER THAT IS CRITICAL TO EMT. THE GOAL OF THIS STUDY WAS TO DETERMINE WHETHER DNMTS WERE INVOLVED IN TGF-BETA1-INDUCED EMT AND ELUCIDATE THE UNDERLYING MECHANISMS IN NASAL EPITHELIAL CELLS AND AIR-LIQUID INTERFACE CULTURES. GLOBAL DNA METHYLATION AND DNMT ACTIVITY WERE QUANTIFIED. DNMT EXPRESSION WAS MEASURED USING REAL-TIME PCR (QRT-PCR) IN HUMAN CRS TISSUES. MRNA AND PROTEIN LEVELS OF DNMTS, E-CADHERIN, VIMENTIN, ALPHA-SMA, AND FIBRONECTIN WERE DETERMINED USING RT-PCR AND WESTERN BLOTTING, RESPECTIVELY. DNMT1, DNMT3A, AND DNMT3B GENE EXPRESSION WERE KNOCKED DOWN USING SIRNA TRANSFECTION. MAPK PHOSPHORYLATION AND EMT-RELATED TRANSCRIPTION FACTOR LEVELS WERE DETERMINED USING WESTERN BLOTTING. SIGNALING PATHWAYS WERE ANALYZED USING SPECIFIC INHIBITORS OF MAPK. WE DEMONSTRATED THESE DATA IN PRIMARY NASAL EPITHELIAL CELLS AND AIR-LIQUID INTERFACE CULTURES. GLOBAL DNA METHYLATION, DNMT ACTIVITY, AND DNMT EXPRESSION INCREASED IN CRS TISSUES. DNMT EXPRESSION WAS POSITIVELY CORRELATED WITH LUND-MCKAY CT SCORES. TGF-BETA1 DOSE-DEPENDENTLY INDUCED DNMT EXPRESSION. FURTHER, 5-AZA INHIBITED TGF-BETA1-INDUCED DNMT, SNAIL, AND SLUG EXPRESSION RELATED TO EMT, AS WELL AS P38 AND JNK PHOSPHORYLATION IN A549 CELLS AND TGF-BETA1-INDUCED DNMT EXPRESSION AND EMT IN PRIMARY NASAL EPITHELIAL CELLS AND AIR-LIQUID INTERFACE CULTURES. TGF-BETA1-INDUCED DNMT EXPRESSION LEADS TO DNA METHYLATION AND EMT VIA P38, JNK, SNAIL, AND SLUG SIGNALING PATHWAYS. INHIBITION OF DNMT SUPPRESSED THE EMT PROCESS AND THEREFORE IS POTENTIALLY A CRS THERAPEUTIC STRATEGY. 2022 10 999 39 CHRONIC SUN EXPOSURE IS ASSOCIATED WITH DISTINCT HISTONE ACETYLATION CHANGES IN HUMAN SKIN. BACKGROUND: PHOTOAGEING IS ATTRIBUTED TO CONTINUOUS SUNLIGHT OR ARTIFICIAL ULTRAVIOLET EXPOSURE AND MANIFESTS AS CLINICAL AND HISTOLOGICAL CHANGES IN SKIN. EPIGENETIC CHANGES HAVE BEEN FOUND TO BE INVOLVED IN THE PATHOGENESIS OF PHOTOAGEING. HOWEVER, THE UNDERLYING MECHANISMS ARE UNCLEAR. OBJECTIVES: TO ANALYSE HISTONE MODIFICATION PATTERNS IN SUN-EXPOSED AND NONEXPOSED SKIN, AND TO IDENTIFY THE ABNORMALLY HISTONE-MODIFIED GENES RELATED TO PHOTOAGEING. METHODS: SKIN BIOPSIES WERE COLLECTED FROM BOTH THE OUTER FOREARM (SUN-EXPOSED AREA) AND THE BUTTOCK (SUN-PROTECTED AREA) IN 20 HEALTHY MIDDLE-AGED FEMALE VOLUNTEERS. GLOBAL HISTONE H3/H4 ACETYLATION AND H3K4/H3K9 METHYLATION STATUSES WERE ASSESSED BY ENZYME-LINKED IMMUNOSORBENT ASSAY. EXPRESSION LEVELS OF HISTONE ACETYLTRANSFERASES AND HISTONE DEACETYLASES WERE MEASURED BY REVERSE-TRANSCRIPTASE QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR) AND WESTERN BLOT. CHROMATIN IMMUNOPRECIPITATION COMBINED WITH DNA MICROARRAY (CHIP-CHIP) ASSAY WITH ANTI-ACETYL-HISTONE H3 ANTIBODY IN A SUN-EXPOSED POOL (COMBINING SIX SUN-EXPOSED SKIN SAMPLES) AND A NONEXPOSED POOL (COMBINING SIX NONEXPOSED SKIN SAMPLES) WAS CONDUCTED TO EXPLORE THE ABNORMALLY ACETYLATED HISTONE H3 GENES RELATED TO PHOTOAGEING; CHIP-QPCR WAS THEN USED TO VERIFY THE RESULTS OF CHIP-CHIP. RESULTS: WE OBSERVED HIGHER GLOBAL HISTONE H3 ACETYLATION LEVELS INCREASED EP300 AND DECREASED HDAC1 AND SIRT1 EXPRESSION IN SUN-EXPOSED SKIN COMPARED WITH MATCHED NONEXPOSED SKIN. FURTHERMORE, THE CHIP-CHIP ASSAY SHOWED THAT 227 GENES DISPLAYED SIGNIFICANT HYPERACETYLATION OF HISTONE H3, AND 81 GENES DISPLAYED SIGNIFICANT HYPOACETYLATION OF HISTONE H3 BETWEEN THE TWO GROUPS. HISTONE H3 ACETYLATION LEVELS ON THE PROMOTERS OF PDCD5, ITIH5, MMP1 AND AHR WERE POSITIVELY CORRELATED WITH THE MRNA EXPRESSION OF THE CORRESPONDING GENE. CONCLUSIONS: CHRONIC SUN EXPOSURE-INDUCED HISTONE H3 HYPERACETYLATION MAY PLAY A CRITICAL ROLE IN THE PATHOGENESIS OF SKIN PHOTOAGEING. 2018 11 1236 34 CURCUMIN AMELIORATES NEPHROSCLEROSIS VIA SUPPRESSION OF HISTONE ACETYLATION INDEPENDENT OF HYPERTENSION. BACKGROUND: ALTHOUGH HISTONE ACETYLATION, AN EPIGENETIC MODIFICATION, HAS BEEN REPORTED TO BE RELATED TO THE PROGRESSION OF VARIOUS DISEASES, ITS INVOLVEMENT IN NEPHROSCLEROSIS IS UNCLEAR. METHODS: DAHL SALT-SENSITIVE RATS WERE USED AS A MODEL OF NEPHROSCLEROSIS IN THIS STUDY. THE RATS WERE DIVIDED INTO THREE GROUPS: (I) NORMAL-SALT DIET GROUP, (II) HIGH-SALT DIET GROUP (HS), AND (III) HS ADMINISTERED DAILY WITH CURCUMIN, A HISTONE ACETYLTRANSFERASE INHIBITOR (HS+C). AT 6 WEEKS AFTER THE TREATMENT, THE KIDNEYS WERE DISSECTED. MORPHOLOGIC CHANGES WERE ASSESSED BY MASSON'S TRICHROME STAINING. THE NUMBER OF MACROPHAGES, FIBROBLASTS AND THE CELLS EXPRESSING ACETYLATED HISTONE H3 AT LYS 9 (H3K9) WERE ASSESSED BY IMMUNOHISTOCHEMISTRY. RESULTS: ALTHOUGH BOTH HS AND HS+C RATS REVEALED A MARKED INCREASE IN SYSTOLIC BLOOD PRESSURE, SERUM CREATININE WAS INCREASED ONLY IN HS RATS AT 6 WEEKS. IN THE HS RATS, NEPHROSCLEROSIS WAS INDUCED, ACCOMPANYING A SIGNIFICANT ACCUMULATION OF MACROPHAGES AND FIBROBLASTS. THE INFLAMMATION AND FIBROSIS WAS MARKEDLY SUPPRESSED IN THE HS+C GROUP. THE LEVEL OF HISTONE ACETYLATION AT LYS 9 WAS ENHANCED IN THE HS RATS, WHEREAS CURCUMIN ADMINISTRATION SUPPRESSED THE HISTONE ACETYLATION. MOREOVER, IN THE HS RATS, INTERLEUKIN-6 GENE EXPRESSION WAS ASSOCIATED WITH ACETYLATED H3K9, AS REVEALED BY CHROMATIN IMMUNOPRECIPITATION ASSAY. CONCLUSIONS: OUR RESULTS SUGGESTED THAT CURCUMIN AMELIORATES NEPHROSCLEROSIS VIA SUPPRESSION OF HISTONE ACETYLATION, INDEPENDENTLY OF HYPERTENSION. 2016 12 1826 44 EFFECTS OF HISTONE DEACETYLASE INHIBITOR ON EXTRACELLULAR MATRIX PRODUCTION IN HUMAN NASAL POLYP ORGAN CULTURES. BACKGROUND: NASAL POLYPOSIS IS ASSOCIATED WITH A CHRONIC INFLAMMATORY CONDITION OF THE SINONASAL MUCOSA AND INVOLVES MYOFIBROBLAST DIFFERENTIATION AND EXTRACELLULAR MATRIX (ECM) ACCUMULATION. EPIGENETIC MODULATION BY HISTONE DEACETYLASE (HDAC) INHIBITORS INCLUDING TRICHOSTATIN A (TSA) HAS BEEN REPORTED TO HAVE INHIBITORY EFFECTS ON MYOFIBROBLAST DIFFERENTIATION IN LUNG AND RENAL FIBROBLASTS. THE PURPOSE OF THIS STUDY WAS TO INVESTIGATE THE INHIBITORY EFFECT OF TSA ON MYOFIBROBLAST DIFFERENTIATION AND ECM PRODUCTION IN NASAL POLYP ORGAN CULTURES. METHODS: NASAL POLYP TISSUES FROM 18 PATIENTS WERE ACQUIRED DURING ENDOSCOPIC SINUS SURGERY. AFTER ORGAN CULTURE, NASAL POLYPS WERE STIMULATED WITH TGF-BETA1 AND THEN TREATED WITH TSA. ALPHA-SMOOTH MUSCLE ACTIN (ALPHA-SMA), FIBRONECTIN, AND COLLAGEN TYPE I EXPRESSION LEVELS WERE EXAMINED BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (PCR), REAL-TIME PCR, WESTERN BLOT, AND IMMUNOFLUORESCENT STAINING. HDAC2, HDAC4, AND ACETYLATED H4 EXPRESSION LEVELS WERE ASSAYED BY WESTERN BLOT. CYTOTOXICITY WAS ANALYZED BY THE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE BIOTIN-DUTP NICK END LABELING ASSAY. RESULTS: THE EXPRESSION LEVELS OF ALPHA-SMA, FIBRONECTIN, AND COLLAGEN TYPE 1 WERE INCREASED IN NASAL POLYP AFTER TRANSFORMING GROWTH FACTOR (TGF) BETA1 TREATMENT. TSA-INHIBITED TGF-BETA1 INDUCED THESE GENE AND PROTEIN EXPRESSION LEVELS. FURTHERMORE, TSA SUPPRESSED PROTEIN EXPRESSION LEVELS OF HDAC2 AND HDAC4. HOWEVER, TSA INDUCED HYPERACETYLATION OF HISTONES H4. TREATMENT WITH TGF-BETA1 WITH OR WITHOUT TSA DID NOT HAVE CYTOTOXIC EFFECT. CONCLUSION: THESE FINDINGS PROVIDE NOVEL INSIGHTS INTO THE EPIGENETIC REGULATION IN MYOFIBROBLAST DIFFERENTIATION AND ECM PRODUCTION OF NASAL POLYP. TSA COULD BE A CANDIDATE OF A THERAPEUTIC AGENT FOR REVERSING THE TGF-BETA1-INDUCED ECM SYNTHESIS THAT LEADS TO NASAL POLYP DEVELOPMENT. 2013 13 3088 31 GENOMEWIDE HISTONE H3 LYSINE 9 ACETYLATION PROFILING IN CD4+ T CELLS REVEALED ENDOPLASMIC RETICULUM STRESS DEFICIENCY IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE. ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) DISPLAYED 'SEPSIS-LIKE' IMMUNE PARALYSIS. LITTLE IS KNOWN ABOUT THE ROLE OF CD4+ T LYMPHOCYTES, THE PRIMARY REGULATOR OF INNATE AND ADOPTED IMMUNE SYSTEM, PLAYED IN ACLF. ACETYLATION OF HISTONE H3 LYSINE 9 (H3K9AC), A KEY EPIGENETIC MODIFICATION, TIGHTLY CONTROLS GENE TRANSCRIPTION. WHETHER AND HOW DOES H3K9AC MODIFICATION REGULATE CD4+ T CELLS IN ACLF REMAINS UNCLEAR. PBMCS WERE ISOLATED FROM PATIENTS WITH ACLF, IMMUNE TOLERANCE OF CHRONIC HEPATITIS B (CHB-T) AND IMMUNE ACTIVE OF CHRONIC HEPATITIS B (CHB-A). THEN, CD4+ T LYMPHOCYTES WERE PURIFIED BY MAGNETIC MICROBEADS, AND THE PURITY WAS CONFIRMED BY FLOW CYTOMETRY. H3K9AC VARIATIONS WERE ANALYSED IN CD4+ T CELLS USING CHROMATIN IMMUNOPRECIPITATION MICROARRAY AND THEN CONFIRMED BY QUANTITATIVE PCR. WHOLE-GENOME H3K9 ACETYLATION ANALYSES WERE CONDUCTED BY BIOINFORMATICS. A TOTAL OF 70 GENES WERE DIFFERENTLY MODIFIED IN H3K9AC BETWEEN CHB-A AND ACLF GROUPS, WHILE 44 GENES WERE DIFFERENTLY MODIFIED IN H3K9AC BETWEEN CHB-T AND ACLF GROUPS. CLUSTERING ALGORITHM ANALYSIS SHOWED PATIENTS WITH ACLF DISPLAYED 'SEPSIS-LIKE' IMMUNE PARALYSIS. FUNCTIONAL ANALYSIS SHOWED ENDOPLASMIC RETICULUM (ER) STRESS, OR DOWNSTREAM PATHWAY-RELATED GENES, SUCH AS BIP, ATF4, PER1, CSNK1D, IRF3, BNIP1, AKT1 AND UBC, WERE DIFFERENTIALLY MODIFIED IN ACLF. WE PROFILED H3K9 ACETYL MODIFICATION IN CD4+ T LYMPHOCYTES FROM HBV-INFECTED PATIENTS WITH THREE DIFFERENT IMMUNE STATES, THAT IS ACLF, IMMUNE TOLERANCE AND IMMUNE ACTIVE PHASES. ACLF DISPLAYED 'SEPSIS-LIKE' IMMUNE PARALYSIS. ER STRESS IN CD4+ T LYMPHOCYTES ATTRIBUTED TO ACLF. THIS STUDY PROVIDES SOME USEFUL CLUES FOR REVEALING THE MECHANISMS UNDERLYING ACLF. 2015 14 5850 33 SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) REDUCES FIBROSIS MARKERS AND DEACTIVATES HUMAN STELLATE CELLS VIA THE EPITHELIAL-MESENCHYMAL TRANSITION (EMT). HEPATIC FIBROSIS IS KNOWN AS THE ACCUMULATION OF CONNECTIVE TISSUE SECONDARY TO CHRONIC DAMAGE TO THE LIVER. EPITHELIAL-MESENCHYMAL TRANSITION (EMT) CORRESPONDING INCREASE IN LIVER FIBROGENESIS WAS SHOWN WITH IMMUNOHISTOCHEMISTRY AND PCR-BASED STUDIES. SUBEROYLANILIDE HYDROXAMIC ACID (SAHA), A SYNTHETIC COMPOUND APPROVED AS A HISTONE DEACETYLASE INHIBITOR (HDAC) BY THE FDA TO TREAT CUTANEOUS T-CELL LYMPHOMA IS UNDER INVESTIGATION FOR THE TREATMENT OF LUNG AND RENAL FIBROSIS. EXPERIMENTAL MODELING FOR HEPATIC FIBROSIS CAN BE CONSTRUCTED WITH AN LX2 CELL LINE ISOLATED FROM HUMAN HEPATIC STELLATE CELLS (HSCS). IN THIS STUDY, WE AIMED TO INVESTIGATE THE MODULATION OF SAHA IN THE PATHOGENESIS OF LIVER FIBROSIS BY DETECTING THE LEVELS OF PROTEINS; (E-CADHERIN (E-CAD), N-CADHERIN (N-CAD), VIMENTIN (VIM), AND GENES; E-CAD, N-CAD, VIM, TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA), ALPHA-SMOOTH MUSCLE ACTIN (ALPHA-SMA), TYPE 1 COLLAGEN (COL1A1), TYPE 3 COLLAGEN (COL3A1)) THAT PLAY A SIGNIFICANT ROLE IN EMT WITH THE LX2 CELL LINE. WE ALSO EVALUATED THE ACTION OF SAHA WITH CELL PROLIFERATION, CLONOGENIC, AND MIGRATION ASSAY. CELL PROLIFERATION WAS PERFORMED BY FLOW CYTOMETRY. ALL THE PROTEIN LEVELS WERE DETERMINED BY WESTERN BLOT ANALYSIS, AND GENE EXPRESSION LEVELS WERE MEASURED BY REAL-TIME PCR. OUR STUDY OBSERVED THAT SAHA TREATMENT DECREASED CELL VIABILITY, COLONY FORMATION AND MIGRATION IN LX2 CELLS. WE FOUND THAT SAHA INCREASED E-CAD EXPRESSION LEVEL, WHILE IT DECREASED N-CAD, VIM, COL1A1, COL3A1, ALPHA-SMA TGF-BETA GENES EXPRESSION LEVELS. SAHA DECREASED THE LEVEL OF E-CAD, N-CAD, AND VIM PROTEIN LEVELS. WE THOUGHT THAT SAHA POSSESSES POTENT ANTIFIBROTIC AND ANTI-EMT PROPERTIES IN LX2. 2021 15 6069 38 THE DIOXIN RECEPTOR IS SILENCED BY PROMOTER HYPERMETHYLATION IN HUMAN ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH INHIBITION OF SP1 BINDING. THE TRANSCRIPTION FACTOR ARYL HYDROCARBON RECEPTOR (AHR) HAS RELEVANT FUNCTIONS IN CELL PROLIFERATION. INTERESTINGLY, THE AHR CAN EITHER PROMOTE OR INHIBIT PROLIFERATION DEPENDING ON THE CELL PHENOTYPE. ALTHOUGH RECENT DATA REVEAL POTENTIAL PATHWAYS FOR AHR SIGNALING IN CELL PROLIFERATION, THE MECHANISMS THAT REGULATE ITS ACTIVITY IN TUMOR CELLS REMAIN UNKNOWN. HERE, WE HAVE ANALYZED PROMOTER HYPERMETHYLATION AS A POTENTIAL MECHANISM CONTROLLING AHR EXPRESSION IN HUMAN TUMOR CELLS. AHR PROMOTER CPG METHYLATION WAS SPORADIC IN A PANEL OF 19 TUMOR CELL LINES EXCEPT FOR THE CHRONIC MYELOID LEUKEMIA (CML) K562 AND THE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) REH. WHEN COMPARED WITH NORMAL LYMPHOCYTES, REH HAD VERY LOW CONSTITUTIVE AHR EXPRESSION THAT COULD BE ATTRIBUTED TO PROMOTER HYPERMETHYLATION SINCE TREATMENT WITH THE DNA DEMETHYLATING AGENT 5-AZA-2'-DEOXYCITIDINE (AZA) SIGNIFICANTLY INCREASED AHR MRNA AND PROTEIN. THESE RESULTS IN LEUKEMIA-DERIVED CELL LINES WERE FURTHER CONFIRMED IN PRIMARY ALL, WHERE 33% OF THE PATIENTS (7/21) HAD AHR PROMOTER HYPERMETHYLATION. CHROMATIN IMMUNOPRECIPITATION (CHIP) SHOWED THAT METHYLATION IMPAIRED BINDING OF THE TRANSCRIPTION FACTOR SP1 TO THE AHR PROMOTER, THUS PROVIDING A MECHANISM FOR AHR DOWNREGULATION IN REH CELLS. THEREFORE, PROMOTER HYPERMETHYLATION REPRESENTS A NOVEL EPIGENETIC MECHANISM DOWNREGULATING AHR ACTIVITY IN HEMATOLOGICAL MALIGNANCIES SUCH AS ALL. 2006 16 5760 48 SOLUBLE URIC ACID PRIMES TLR-INDUCED PROINFLAMMATORY CYTOKINE PRODUCTION BY HUMAN PRIMARY CELLS VIA INHIBITION OF IL-1RA. OBJECTIVES: THE STUDY OF THE PROINFLAMMATORY ROLE OF URIC ACID HAS FOCUSED ON THE EFFECTS OF ITS CRYSTALS OF MONOSODIUM URATE (MSU). HOWEVER, LITTLE IS KNOWN WHETHER URIC ACID ITSELF CAN DIRECTLY HAVE PROINFLAMMATORY EFFECTS. IN THIS STUDY, WE INVESTIGATE THE PRIMING EFFECTS OF URIC ACID EXPOSURE ON THE CYTOKINE PRODUCTION OF PRIMARY HUMAN CELLS UPON STIMULATION WITH GOUT-RELATED STIMULI. METHODS: PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) WERE HARVESTED FROM PATIENTS WITH GOUT AND HEALTHY VOLUNTEERS. CELLS WERE PRETREATED WITH OR WITHOUT URIC ACID IN SOLUBLE FORM FOR 24 H AND THEN STIMULATED FOR 24 H WITH TOLL-LIKE RECEPTOR (TLR)2 OR TLR4 LIGANDS IN THE PRESENCE OR ABSENCE OF MSU CRYSTALS. CYTOKINE PRODUCTION WAS MEASURED BY ELISA; MRNA LEVELS WERE ASSESSED USING QPCR. RESULTS: THE PRODUCTION OF INTERLEUKIN (IL)-1BETA AND IL-6 WAS HIGHER IN PATIENTS COMPARED WITH CONTROLS AND THIS CORRELATED WITH SERUM URATE LEVELS. PROINFLAMMATORY CYTOKINE PRODUCTION WAS SIGNIFICANTLY POTENTIATED WHEN CELLS FROM HEALTHY SUBJECTS WERE PRETREATED WITH URIC ACID. SURPRISINGLY, THIS WAS ASSOCIATED WITH A SIGNIFICANT DOWNREGULATION OF THE ANTI-INFLAMMATORY CYTOKINE IL-1 RECEPTOR ANTAGONIST (IL-1RA). THIS EFFECT WAS SPECIFIC TO STIMULATION BY URIC ACID AND WAS EXERTED AT THE LEVEL OF GENE TRANSCRIPTION. EPIGENETIC REPROGRAMMING AT THE LEVEL OF HISTONE METHYLATION BY URIC ACID WAS INVOLVED IN THIS EFFECT. CONCLUSIONS: IN THIS STUDY WE DEMONSTRATE A MECHANISM THROUGH WHICH HIGH CONCENTRATIONS OF URIC ACID (UP TO 50 MG/DL) INFLUENCE INFLAMMATORY RESPONSES BY FACILITATING IL-1BETA PRODUCTION IN PBMCS. WE SHOW THAT A MECHANISM FOR THE AMPLIFICATION OF IL-1BETA CONSISTS IN THE DOWNREGULATION OF IL-1RA AND THAT THIS EFFECT COULD BE EXERTED VIA EPIGENETIC MECHANISMS SUCH AS HISTONE METHYLATION. HYPERURICAEMIA CAUSES A SHIFT IN THE IL-1BETA/IL-1RA BALANCE PRODUCED BY PBMCS AFTER EXPOSURE TO MSU CRYSTALS AND TLR-MEDIATED STIMULI, AND THIS PHENOMENON IS LIKELY TO REINFORCE THE ENHANCED STATE OF CHRONIC INFLAMMATION. 2016 17 3246 27 HEPATITIS B VIRUS (HBV) INDUCES THE EXPRESSION OF INTERLEUKIN-8 THAT IN TURN REDUCES HBV SENSITIVITY TO INTERFERON-ALPHA. HIGH LEVELS OF SERUM INTERLEUKIN-8 (IL-8) HAVE BEEN DETECTED IN CHRONIC HEPATITIS B (CHB) PATIENTS DURING EPISODES OF HEPATITIS FLARES. WE INVESTIGATED WHETHER HEPATITIS B VIRUS (HBV) MAY DIRECTLY INDUCE IL-8 PRODUCTION AND WHETHER IL-8 MAY ANTAGONIZE INTERFERON-ALPHA (IFN-ALPHA) ANTIVIRAL ACTIVITY AGAINST HBV. WE SHOWED THAT CHB PATIENTS HAD SIGNIFICANTLY HIGHER IL-8 LEVELS BOTH IN SERUM AND IN LIVER TISSUE THAN CONTROLS. IN HBV-REPLICATING HEPG2 CELLS, IL-8 TRANSCRIPTION WAS SIGNIFICANTLY ACTIVATED. AP-1, C/EBP AND NF-KB TRANSCRIPTION FACTORS WERE CONCURRENTLY NECESSARY FOR MAXIMUM IL-8 INDUCTION. MOREOVER, HBX VIRAL PROTEIN WAS RECRUITED ONTO THE IL-8 PROMOTER AND THIS WAS PARALLELED BY IL8-BOUND HISTONE HYPERACETYLATION AND BY ACTIVE RECRUITMENT OF TRANSCRIPTIONAL COACTIVATORS. INHIBITION OF IL-8 INCREASES THE ANTIVIRAL ACTIVITY OF IFN-ALPHA AGAINST HBV. OUR RESULTS INDICATE THAT HBV ACTIVATES IL-8 GENE EXPRESSION BY TARGETING THE EPIGENETIC REGULATION OF THE IL-8 PROMOTER AND THAT IL-8 MAY CONTRIBUTE TO REDUCE HBV SENSITIVITY TO IFN-ALPHA. 2013 18 5854 29 SUBSTANCE P AND NEPRILYSIN IN CHRONIC PANCREATITIS. BACKGROUND/AIMS: WE AIMED TO ANALYZE SUBSTANCE P (SP) AND NEPRILYSIN (NEP), THE MEMBRANE METALLOPEPTIDASE THAT DEGRADES SP, IN CHRONIC PANCREATITIS (CP). METHODS: SP AND NEP MRNA LEVELS WERE ANALYZED BY QRT-PCR IN TISSUE SAMPLES FROM 30 PATIENTS WITH CP AND 8 ORGAN DONORS. IN ADDITION, SP SERUM LEVELS WERE DETERMINED BEFORE AND AFTER SURGERY IN THE SAME PATIENTS, BY MEANS OF A COMPETITIVE ELISA ASSAY. GENETIC AND EPIGENETIC ANALYSES OF THE NEP GENE WERE ALSO PERFORMED. RESULTS: SP MRNA EXPRESSION LEVELS WERE HIGHER IN CP TISSUES COMPARED TO CONTROLS (P = 0.0152), WHILE NEP MRNA SHOWED NO SIGNIFICANT DIFFERENCES BETWEEN CP AND HEALTHY SUBJECTS (P = 0.2102). IN CP PATIENTS, SP SERUM LEVELS CORRELATED WITH THOSE IN TISSUE, AND AFTER SURGICAL RESECTION SP SERUM LEVELS WERE REDUCED COMPARED TO THE PREOPERATIVE VALUES. FAILURE OF NEP TO OVEREXPRESS IN CP TISSUES WAS ASSOCIATED WITH SIGNIFICANT MIR-128A OVEREXPRESSION (P = 0.02), RATHER THAN WITH MUTATIONS IN THE NEP CODING REGION OR THE PRESENCE OF HYPERMETHYLATION SITES IN THE NEP PROMOTER REGION. CONCLUSION: TISSUE AND SERUM LEVELS OF SP WERE INCREASED IN CP, WHILE NEP LEVELS REMAINED UNALTERED. IN AN SP/NEP-MEDIATED PATHWAY, IT WOULD APPEAR THAT NEP FAILS TO PROVIDE ADEQUATE SURVEILLANCE OF SP LEVELS. FAILURE OF NEP TO OVEREXPRESS COULD BE ASSOCIATED WITH MIRNA REGULATION. 2012 19 4349 29 MIR-155 AND MIR-122 EXPRESSION OF SPERMATOZOA IN OBESE SUBJECTS. OBESITY IS CHARACTERIZED BY MILD CHRONIC INFLAMMATION THAT IS LINKED WITH IMPAIRED IRON HOMEOSTASIS. STUDIES IN HUMAN AND MURINE SHOW THAT THERE IS A TRANSGENERATIONAL EPIGENETIC INHERITANCE VIA THE GAMETES IN OBESITY; HOWEVER, THERE IS LITTLE INFORMATION ON CHANGES IN THE EXPRESSION OF MICRORNAS RELATED TO INFLAMMATION AND IRON HOMEOSTASIS IN SPERMATOZOA FROM OBESE SUBJECTS. THE PRESENT STUDY INVESTIGATED THE EXPRESSION OF MICRORNAS RELATED TO INFLAMMATION (MIR-21 Y MIR-155) AND IRON NUTRITION (MIR-122 AND MIR-200B) IN PLASMA, PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC) AND SPERMATOZOA FROM NORMOZOOSPERMIC CONTROLS (CN; N = 17; BMI: 24.6 +/- 2.0) AND OBESE (OB; N = 17; BMI: 32.6 +/- 4.4) MEN. TO DETERMINE THE INFLAMMATION LEVELS, WE MEASURED IL-6, TNF-ALPHA, AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP1) BY MAGNETIC LUMINEX((R)) ASSAY. MRNA EXPRESSION OF IL6, TNF-ALPHA, AND HEPCIDIN (HAMP) IN PBMC WERE EVALUATED BY RT-QPCR. THE ANALYSIS OF MICRORNAS WAS PERFORMED USING THE TAQMAN((R)) ASSAYS. THE IRON CONTENT IN PBMC, SEMINAL PLASMA, AND SPERMATOZOA WAS DETERMINED BY INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY (ICP-MS). HIGH SERUM IL6, TNF-ALPHA, AND MCP1 LEVELS WERE OBSERVED IN OB GROUP (P < 0.05). GENE EXPRESSION ANALYSIS SHOWED AN INCREASED ABUNDANCE RELATIVE OF TNF-ALPHA (P = 0.018), HAMP (P = 0.03), AND IL6 (P = 0.02) IN PBMC FROM OBESE SUBJECTS. ALSO, WE OBSERVED HIGH LEVELS OF SERUM FERRITIN (P = 0.03), IRON CONTENT IN SEMINAL PLASMA (P = 0.04), AND SPERMATOZOA (P = 0.002), BUT LOWER SERUM FE (P = 0.007) IN OBESE SUBJECTS. IN THE OB GROUP, A HIGH EXPRESSION OF MIR-155 (P = 0.02) AND MIR-21 (P = 0.03) WAS OBSERVED IN PBMC AND MIR-122 (P = 0.03) IN PLASMA. IN SPERM, BOTH MIR-155 (P = 0.004) AND MIR-122 (P = 0.028) WERE HIGH IN THE OB GROUP. OUR RESULTS SHOWED THAT OBESE SUBJECTS HAVE INCREASED EXPRESSIONS OF MIR-155 AND MIR-122, TWO MICRORNAS THAT WERE PREVIOUSLY RELATED WITH INFLAMMATION AND IRON METABOLISM, RESPECTIVELY, AT BOTH THE SYSTEMIC AND SPERM LEVELS. 2018 20 2742 36 EXPOSURE TO THE PLASTICIZER, DI-(2-ETHYLHEXYL) PHTHALATE DURING JUVENILE PERIOD EXACERBATES AUTISM-LIKE BEHAVIOR IN ADULT BTBR T + TF/J MICE DUE TO DNA HYPOMETHYLATION AND ENHANCED INFLAMMATION IN BRAIN AND SYSTEMIC IMMUNE CELLS. EPIGENETIC MODIFICATIONS ARE KNOWN TO PLAY A CRUCIAL ROLE IN THE BEHAVIORAL MODIFICATIONS THROUGH REGULATION OF GENE EXPRESSION. ENVIRONMENTAL FACTORS ARE KNOWN TO REGULATE GENETIC TRANSCRIPTION THROUGH DNA METHYLATION WHICH IS ONE OF THE MECHANISMS OF EPIGENETIC MODIFICATION. DI-2-ETHYLHEXYL PHTHALATE (DEHP) IS ONE OF THE MOST ABUNDANT PHTHALATE PLASTICIZERS IN DAY-TO-DAY PRODUCTS. PRENATAL/POSTNATAL DEHP ADMINISTRATION HAS BEEN REPORTED TO CAUSE INFLAMMATION AS WELL AS BEHAVIORAL DYSREGULATION, HOWEVER IT IS NOT KNOWN IF EXPOSURE TO DEHP DURING JUVENILE STAGE AFFECTS PERIPHERAL/NEURONAL INFLAMMATION AND AUTISM-LIKE SYMPTOMS IN BTBR MICE AT ADULTHOOD. THIS STUDY INVESTIGATED EFFECT OF DEHP EXPOSURE DURING JUVENILE PERIOD ON DNA METHYLATION (GLOBAL DNA METHYLATION/DNMT1 EXPRESSION) AND INFLAMMATION (IL-17A, IL-6, MCP-1, TNF-ALPHA) IN CD4 + T CELLS/CD11C + DCS AND CORTEX, AND AUTISM-LIKE SYMPTOMS (THREE-CHAMBERED SOCIABILITY TEST, SELF-GROOMING AND MARBLE BURYING TEST) IN ASOCIAL BTBR AND SOCIAL C57 MICE AT ADULTHOOD. OUR DATA REVEAL THAT BTBR MICE EXPOSED TO DEHP DURING JUVENILE PERIOD HAVE HYPOMETHYLATED DNA/DNMT1 EXPRESSION IN CD11C + DCS AND CORTEX AS COMPARED TO VEHICLE-EXPOSED BTBR MICE. IT WAS ASSOCIATED WITH UPREGULATED INFLAMMATION IN PERIPHERY [PLASMA IL-6/IL-17A, CD11C + DCS (IL-6/MCP-1/TNF-ALPHA), AND CD4+ T CELLS (IL-17A)] AND CORTEX (IL-6, MCP-1, TNF-ALPHA), AND AGGRAVATION IN AUTISM-LIKE SYMPTOMS IN DEHP-TREATED BTBR MICE. THESE DATA PROPOSE THAT EXPOSURE OF DEHP DURING JUVENILE PERIOD MAY AFFECT AUTISM-LIKE BEHAVIOR AND INFLAMMATION IN BTBR MICE AT ADULTHOOD THROUGH EPIGENETIC REGULATION. THEREFORE, UNDERLYING GENETIC PREDISPOSITION MAY PLAY A CRUCIAL ROLE IN WORSENING OF AUTISTIC SYMPTOMS IN ASD SUBJECTS IN ADULTHOOD IF THEY ARE EXPOSED TO ENVIRONMENTAL POLLUTANTS SUCH AS DEHP DURING JUVENILE PERIOD. 2021